Back to search
Erythema Chronicum Migrans
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Erythema Chronicum Migrans trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Erythema Chronicum Migrans trials you may qualify forThe investigators will focus on pretreatment expectations of patients with early Lyme disease manifested as erythema migrans with the aim of assessing the assoc…
The purpose of this study is to compare the efficacy of 7-day versus 14-day doxycycline treatment in patients with multiple erythema migrans.
The purpose of this study is to compare the efficacy of different amoxicilline treatment regimens in patients with erythema migrans.
The aim of this study is to assess the effect of Saccharomyces boulardii CNCM I-745 on gut microbiota in patients undergoing antibiotic therapy (in the context…
Test and evaluate a new diagnostic method (SRM-MS/MS: Selected Reaction Monitoring- Mass spectrometry) for Lyme Borreliosis on human skin biopsies. Patients inc…
Background Lyme borreliosis, caused by Borrelia burgdorferi sensu lato is transmitted to humans through the bite of an infected Ixodes tick. B. burgdorferi sens…
The aim of this study is to identify the species of Borrelia involved in the dermatologic manifestations of Lyme borreliosis in France. Indeed, in Europe, as op…